Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
editorial
. 1982 Apr 3;284(6321):997–998. doi: 10.1136/bmj.284.6321.997

Measles eradication policies.

N D Noah
PMCID: PMC1497976  PMID: 6802404

Full text

PDF
997

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adjaye N. Measles immunization. Some factors affecting non-acceptance of vaccine. Public Health. 1981 Jul;95(4):185–188. doi: 10.1016/s0033-3506(81)80069-8. [DOI] [PubMed] [Google Scholar]
  2. Albritton R. B. Cost-benefits of measles eradication: effects of a federal intervention. Policy Anal. 1978 Winter;4(1):1–21. [PubMed] [Google Scholar]
  3. Bussey A. L., Harris A. S. Computers and the effectiveness of the measles vaccination campaign in England and Wales. Community Med. 1979 Feb;1(1):29–35. doi: 10.1007/BF02548740. [DOI] [PubMed] [Google Scholar]
  4. Bussey A. L., Holmes B. S. Immunisation levels---need they all decline? Lancet. 1977 Nov 5;2(8045):970–971. doi: 10.1016/s0140-6736(77)90903-5. [DOI] [PubMed] [Google Scholar]
  5. Creese A. L., Henderson R. H. Cost-benefit analysis and immunization programmes in developing countries. Bull World Health Organ. 1980;58(3):491–497. [PMC free article] [PubMed] [Google Scholar]
  6. Frank J. A., Jr, Hoffman R. E., Mann J. M., Crowe J. D., Hinman A. R. Imported measles. A potential control problem. JAMA. 1981 Jan 16;245(3):264–266. [PubMed] [Google Scholar]
  7. Miller C. L. Severity of notified measles. Br Med J. 1978 May 13;1(6122):1253–1253. doi: 10.1136/bmj.1.6122.1253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Miller C. Measles again. Br Med J. 1980 Jun 14;280(6229):1451–1451. doi: 10.1136/bmj.280.6229.1451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Robbins K. B., Brandling-Bennett D., Hinman A. R. Low measles incidence: association with enforcement of school immunization laws. Am J Public Health. 1981 Mar;71(3):270–274. doi: 10.2105/ajph.71.3.270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rutstein D. D. Controlling the communicable and the man-made diseases. N Engl J Med. 1981 Jun 4;304(23):1422–1424. doi: 10.1056/NEJM198106043042310. [DOI] [PubMed] [Google Scholar]
  11. Smith H. Measles again. Br Med J. 1980 Mar 15;280(6216):766–767. doi: 10.1136/bmj.280.6216.766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Wilkinson P., Tylden-Pattenson L., Gould J. Professional attitudes towards vaccination and immunization within the Leeds Area Health Authority (Teaching). Public Health. 1979 Jan;93(1):11–15. doi: 10.1016/s0033-3506(79)80004-9. [DOI] [PubMed] [Google Scholar]
  13. Witte J. J., Axnick N. W. The benefits from 10 years of measles immunization in the United States. Public Health Rep. 1975 May-Jun;90(3):205–207. [PMC free article] [PubMed] [Google Scholar]
  14. Wright H. J. Acceptance of measles vaccine. Lancet. 1977 Sep 10;2(8037):554–554. doi: 10.1016/s0140-6736(77)90680-8. [DOI] [PubMed] [Google Scholar]
  15. Yorke J. A., Nathanson N., Pianigiani G., Martin J. Seasonality and the requirements for perpetuation and eradication of viruses in populations. Am J Epidemiol. 1979 Feb;109(2):103–123. doi: 10.1093/oxfordjournals.aje.a112666. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES